Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Research article

Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells

Authors: Elisabetta Lambertini, Andrea Lolli, Federica Vezzali, Letizia Penolazzi, Roberto Gambari, Roberta Piva

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

Breast cancer and its metastatic progression is mainly directed by epithelial to mesenchymal transition (EMT), a phenomenon supported by specific transcription factors and miRNAs.

Methods

In order to investigate a possible correlation between Slug transcription factor and miR-221, we performed Slug gene silencing in MDA-MB-231 breast cancer cells and evaluated the expression of genes involved in supporting the breast cancer phenotype, using qRT-PCR and Western blot analysis. Chromatin immunoprecipitation and wound healing assays were employed to determine a functional link between these two molecules.

Results

We showed that Slug silencing significantly decreased the level of miR-221 and vimentin, reactivated Estrogen Receptor α and increased E-cadherin and TRPS1 expression. We demonstrated that miR-221 is a Slug target gene, and identified a specific region of miR-221 promoter that is transcriptionally active and binds the transcription factor Slug “in vivo”. In addition, we showed that in Slug-silenced cells, wich retained residual miR-221 (about 38%), cell migration was strongly inhibited. Cell migration was inhibited, but to a less degree, following complete knockdown of miR-221 expression by transfection with antagomiR-221.

Conclusions

We report for the first time evidence of a correlation between Slug transcription factor and miR-221 in breast cancer cells. These studies suggest that miR-221 expression is, in part, dependent on Slug in breast cancer cells, and that Slug plays a more important role than miR-221 in cell migration and invasion.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nieto MA: The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol. 2011, 27: 347-376. 10.1146/annurev-cellbio-092910-154036.CrossRefPubMed Nieto MA: The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol. 2011, 27: 347-376. 10.1146/annurev-cellbio-092910-154036.CrossRefPubMed
2.
go back to reference Vincent-Salomon A, Thiery JP: Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res. 2003, 5 (2): 101-106. 10.1186/bcr578.CrossRefPubMedPubMedCentral Vincent-Salomon A, Thiery JP: Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res. 2003, 5 (2): 101-106. 10.1186/bcr578.CrossRefPubMedPubMedCentral
3.
go back to reference De Herreros AG, Peiró S, Nassour M, Savagner P: Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia. 2010, 15 (2): 135-147. 10.1007/s10911-010-9179-8.CrossRefPubMedPubMedCentral De Herreros AG, Peiró S, Nassour M, Savagner P: Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia. 2010, 15 (2): 135-147. 10.1007/s10911-010-9179-8.CrossRefPubMedPubMedCentral
4.
go back to reference Barrallo-Gimeno A, Nieto MA: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005, 132 (14): 3151-3161. 10.1242/dev.01907.CrossRefPubMed Barrallo-Gimeno A, Nieto MA: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005, 132 (14): 3151-3161. 10.1242/dev.01907.CrossRefPubMed
5.
go back to reference Thiery JP, Acloque H, Huang RYJ, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139 (5): 871-890. 10.1016/j.cell.2009.11.007.CrossRefPubMed Thiery JP, Acloque H, Huang RYJ, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139 (5): 871-890. 10.1016/j.cell.2009.11.007.CrossRefPubMed
6.
go back to reference Gregory PA, Bracken CP, Bert AG, Goodall GJ: MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle. 2008, 7 (20): 3112-3118. 10.4161/cc.7.20.6851.CrossRefPubMed Gregory PA, Bracken CP, Bert AG, Goodall GJ: MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle. 2008, 7 (20): 3112-3118. 10.4161/cc.7.20.6851.CrossRefPubMed
7.
go back to reference Guttilla IK, Adams BD, White BA: ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer. Trends Endocrinol Metab. 2012, 23 (2): 73-82. 10.1016/j.tem.2011.12.001.CrossRefPubMed Guttilla IK, Adams BD, White BA: ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer. Trends Endocrinol Metab. 2012, 23 (2): 73-82. 10.1016/j.tem.2011.12.001.CrossRefPubMed
8.
go back to reference Wright JA, Richer JK, Goodall GJ: microRNAs and EMT in mammary cells and breast cancer. J Mammary Gland Biol Neoplasia. 2010, 15 (2): 213-223. 10.1007/s10911-010-9183-z.CrossRefPubMed Wright JA, Richer JK, Goodall GJ: microRNAs and EMT in mammary cells and breast cancer. J Mammary Gland Biol Neoplasia. 2010, 15 (2): 213-223. 10.1007/s10911-010-9183-z.CrossRefPubMed
9.
go back to reference Howe EN, Cochrane DR, Richer JK: The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia. 2012, 17 (1): 65-77. 10.1007/s10911-012-9244-6.CrossRefPubMedPubMedCentral Howe EN, Cochrane DR, Richer JK: The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia. 2012, 17 (1): 65-77. 10.1007/s10911-012-9244-6.CrossRefPubMedPubMedCentral
10.
go back to reference Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9 (6): 582-589. 10.1038/embor.2008.74.CrossRefPubMedPubMedCentral Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9 (6): 582-589. 10.1038/embor.2008.74.CrossRefPubMedPubMedCentral
11.
go back to reference Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, Zr Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T: The EMT activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009, 11 (12): 1487-1495. 10.1038/ncb1998.CrossRefPubMed Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, Zr Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T: The EMT activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009, 11 (12): 1487-1495. 10.1038/ncb1998.CrossRefPubMed
12.
go back to reference Reshmi G, Sona C, Pillai MR: Comprehensive patterns in microRNA regulation of transcription factors during tumor metastasis. J Cell Biochem. 2011, 112 (9): 2210-2217. 10.1002/jcb.23148.CrossRefPubMed Reshmi G, Sona C, Pillai MR: Comprehensive patterns in microRNA regulation of transcription factors during tumor metastasis. J Cell Biochem. 2011, 112 (9): 2210-2217. 10.1002/jcb.23148.CrossRefPubMed
13.
go back to reference Wang J, Haubrock M, Cao KM, Hua X, Zhang CY, Wingender E, Li J: Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network. BMC Syst Biol. 2011, 5: 199-10.1186/1752-0509-5-199.CrossRefPubMedPubMedCentral Wang J, Haubrock M, Cao KM, Hua X, Zhang CY, Wingender E, Li J: Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network. BMC Syst Biol. 2011, 5: 199-10.1186/1752-0509-5-199.CrossRefPubMedPubMedCentral
14.
go back to reference Moes M, Le Béchec A, Crespo I, Laurini C, Halavatyi A, Vetter G, Del Sol A, Friederich E: A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One. 2012, 7 (4): e35440-10.1371/journal.pone.0035440.CrossRefPubMedPubMedCentral Moes M, Le Béchec A, Crespo I, Laurini C, Halavatyi A, Vetter G, Del Sol A, Friederich E: A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One. 2012, 7 (4): e35440-10.1371/journal.pone.0035440.CrossRefPubMedPubMedCentral
15.
go back to reference Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K: MiR-1 and miR-200 inhibit EMT via slug-dependent and tumorigenesis via slug-independent mechanisms. Oncogene. 2012, 10.1038/onc.2012.58. in press Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K: MiR-1 and miR-200 inhibit EMT via slug-dependent and tumorigenesis via slug-independent mechanisms. Oncogene. 2012, 10.1038/onc.2012.58. in press
16.
go back to reference Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM: p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 2011, 208 (5): 875-883. 10.1084/jem.20110235.CrossRefPubMedPubMedCentral Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM: p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 2011, 208 (5): 875-883. 10.1084/jem.20110235.CrossRefPubMedPubMedCentral
17.
go back to reference Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O’Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D: TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Sci Signal. 2011, 4 (177): ra41-10.1126/scisignal.2001538.CrossRefPubMed Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O’Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D: TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Sci Signal. 2011, 4 (177): ra41-10.1126/scisignal.2001538.CrossRefPubMed
18.
go back to reference Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher CA, Weiss SJ, Yook JI: A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol. 2011, 195 (3): 417-433. 10.1083/jcb.201103097.CrossRefPubMedPubMedCentral Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher CA, Weiss SJ, Yook JI: A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol. 2011, 195 (3): 417-433. 10.1083/jcb.201103097.CrossRefPubMedPubMedCentral
19.
go back to reference Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ: A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68 (19): 7846-7854. 10.1158/0008-5472.CAN-08-1942.CrossRefPubMed Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ: A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68 (19): 7846-7854. 10.1158/0008-5472.CAN-08-1942.CrossRefPubMed
20.
21.
go back to reference Mancini M, Petta S, Iacobucci I, Salvestrini V, Barbieri E, Santucci MA: Zinc finger transcription factor slug contributes tothe survival advantage of chronic myeloid leukemia cells. Cell Signal. 2010, 22 (8): 1247-1253. 10.1016/j.cellsig.2010.04.002.CrossRefPubMed Mancini M, Petta S, Iacobucci I, Salvestrini V, Barbieri E, Santucci MA: Zinc finger transcription factor slug contributes tothe survival advantage of chronic myeloid leukemia cells. Cell Signal. 2010, 22 (8): 1247-1253. 10.1016/j.cellsig.2010.04.002.CrossRefPubMed
22.
go back to reference Guo Y, Zi X, Koontz Z, Kim A, Xie J, Gorlick R, Holcombe RF, Hoang BH: Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res. 2007, 25 (7): 964-971. 10.1002/jor.20356.CrossRefPubMed Guo Y, Zi X, Koontz Z, Kim A, Xie J, Gorlick R, Holcombe RF, Hoang BH: Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res. 2007, 25 (7): 964-971. 10.1002/jor.20356.CrossRefPubMed
23.
go back to reference Jethwa P, Naqvi M, Hardy RG, Hotchin NA, Roberts S, Spychal R, Tselepis C: Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol. 2008, 14 (7): 1044-1052. 10.3748/wjg.14.1044.CrossRefPubMedPubMedCentral Jethwa P, Naqvi M, Hardy RG, Hotchin NA, Roberts S, Spychal R, Tselepis C: Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol. 2008, 14 (7): 1044-1052. 10.3748/wjg.14.1044.CrossRefPubMedPubMedCentral
24.
go back to reference Côme C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, Savagner P: Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res. 2006, 12 (18): 5395-5402. 10.1158/1078-0432.CCR-06-0478.CrossRefPubMed Côme C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, Savagner P: Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res. 2006, 12 (18): 5395-5402. 10.1158/1078-0432.CCR-06-0478.CrossRefPubMed
25.
go back to reference Vitali R, Mancini C, Cesi V, Tanno B, Mancuso M, Bossi G, Zhang Y, Martinez RV, Calabretta B, Dominici C, Raschellà G: Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasivegrowth in neuroblastoma preclinical models. Clin Cancer Res. 2008, 14 (14): 4622-4630. 10.1158/1078-0432.CCR-07-5210.CrossRefPubMed Vitali R, Mancini C, Cesi V, Tanno B, Mancuso M, Bossi G, Zhang Y, Martinez RV, Calabretta B, Dominici C, Raschellà G: Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasivegrowth in neuroblastoma preclinical models. Clin Cancer Res. 2008, 14 (14): 4622-4630. 10.1158/1078-0432.CCR-07-5210.CrossRefPubMed
26.
go back to reference Howard EW, Camm KD, Wong YC, Wang XH: E-cadherin upregulation as a therapeutic goal in cancer treatment. Mini Rev Med Chem. 2008, 8 (5): 496-518. 10.2174/138955708784223521.CrossRefPubMed Howard EW, Camm KD, Wong YC, Wang XH: E-cadherin upregulation as a therapeutic goal in cancer treatment. Mini Rev Med Chem. 2008, 8 (5): 496-518. 10.2174/138955708784223521.CrossRefPubMed
27.
go back to reference Mimeault M, Batra SK: Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications. Cancer Metastasis Rev. 2007, 26 (1): 203-214. 10.1007/s10555-007-9052-4.CrossRefPubMed Mimeault M, Batra SK: Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications. Cancer Metastasis Rev. 2007, 26 (1): 203-214. 10.1007/s10555-007-9052-4.CrossRefPubMed
28.
go back to reference Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG: Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res. 2007, 13 (16): 4769-4776. 10.1158/1078-0432.CCR-06-2926.CrossRefPubMed Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG: Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res. 2007, 13 (16): 4769-4776. 10.1158/1078-0432.CCR-06-2926.CrossRefPubMed
29.
go back to reference Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA, Farace MG: miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem. 2007, 282 (32): 23716-23724. 10.1074/jbc.M701805200.CrossRefPubMed Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA, Farace MG: miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem. 2007, 282 (32): 23716-23724. 10.1074/jbc.M701805200.CrossRefPubMed
30.
go back to reference Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A: miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA. 2010, 107 (1): 264-269. 10.1073/pnas.0907904107.CrossRefPubMed Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A: miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA. 2010, 107 (1): 264-269. 10.1073/pnas.0907904107.CrossRefPubMed
31.
go back to reference Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Carè A: The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res. 2008, 68 (8): 2745-2754. 10.1158/0008-5472.CAN-07-2538.CrossRefPubMed Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Carè A: The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res. 2008, 68 (8): 2745-2754. 10.1158/0008-5472.CAN-07-2538.CrossRefPubMed
32.
go back to reference Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM: MicroRNA cluster 221–222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst. 2010, 102 (10): 706-721. 10.1093/jnci/djq102.CrossRefPubMedPubMedCentral Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM: MicroRNA cluster 221–222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst. 2010, 102 (10): 706-721. 10.1093/jnci/djq102.CrossRefPubMedPubMedCentral
33.
go back to reference Rao X, Di Leva G, Li M, Fang F, Devlin C, Hartman-Frey C, Burow ME, Ivan M, Croce CM, Nephew KP: MicroRNA221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene. 2011, 30 (9): 1082-1097. 10.1038/onc.2010.487.CrossRefPubMed Rao X, Di Leva G, Li M, Fang F, Devlin C, Hartman-Frey C, Burow ME, Ivan M, Croce CM, Nephew KP: MicroRNA221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene. 2011, 30 (9): 1082-1097. 10.1038/onc.2010.487.CrossRefPubMed
34.
go back to reference Zhao R, Wu J, Jia W, Gong C, Yu F, Ren Z, Chen K, He J, Su F: Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. Onkologie. 2011, 34 (12): 675-680. 10.1159/000334552.CrossRefPubMed Zhao R, Wu J, Jia W, Gong C, Yu F, Ren Z, Chen K, He J, Su F: Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. Onkologie. 2011, 34 (12): 675-680. 10.1159/000334552.CrossRefPubMed
35.
go back to reference Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Barsky SH: ERalpha suppresses slug expression directly by transcriptional repression. Biochem J. 2008, 416 (2): 179-187. 10.1042/BJ20080328.CrossRefPubMedPubMedCentral Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Barsky SH: ERalpha suppresses slug expression directly by transcriptional repression. Biochem J. 2008, 416 (2): 179-187. 10.1042/BJ20080328.CrossRefPubMedPubMedCentral
36.
go back to reference Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH: ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene. 2010, 29 (10): 1451-1462. 10.1038/onc.2009.433.CrossRefPubMed Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH: ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene. 2010, 29 (10): 1451-1462. 10.1038/onc.2009.433.CrossRefPubMed
37.
go back to reference Dhasarathy A, Kajita M, Wade PA: The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol. 2007, 21 (12): 2907-2918. 10.1210/me.2007-0293.CrossRefPubMedPubMedCentral Dhasarathy A, Kajita M, Wade PA: The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol. 2007, 21 (12): 2907-2918. 10.1210/me.2007-0293.CrossRefPubMedPubMedCentral
38.
go back to reference Torreggiani E, Lisignoli G, Manferdini C, Lambertini E, Penolazzi L, Vecchiatini R, Gabusi E, Chieco P, Facchini A, Gambari R, Piva R: Role of Slug transcription factor in human mesenchymal stem cells. J Cell Mol Med. 2012, 16 (4): 740-751. 10.1111/j.1582-4934.2011.01352.x.CrossRefPubMedPubMedCentral Torreggiani E, Lisignoli G, Manferdini C, Lambertini E, Penolazzi L, Vecchiatini R, Gabusi E, Chieco P, Facchini A, Gambari R, Piva R: Role of Slug transcription factor in human mesenchymal stem cells. J Cell Mol Med. 2012, 16 (4): 740-751. 10.1111/j.1582-4934.2011.01352.x.CrossRefPubMedPubMedCentral
39.
go back to reference Lambertini E, Lisignoli G, Torreggiani E, Manferdini C, Gabusi E, Franceschetti T, Penolazzi L, Gambari R, Facchini A, Piva R: Slug gene expression supports human osteoblast maturation. Cell Mol Life Sci. 2009, 66 (22): 3641-3653. 10.1007/s00018-009-0149-5.CrossRefPubMed Lambertini E, Lisignoli G, Torreggiani E, Manferdini C, Gabusi E, Franceschetti T, Penolazzi L, Gambari R, Facchini A, Piva R: Slug gene expression supports human osteoblast maturation. Cell Mol Life Sci. 2009, 66 (22): 3641-3653. 10.1007/s00018-009-0149-5.CrossRefPubMed
40.
go back to reference Penolazzi L, Tavanti E, Vecchiatini R, Lambertini E, Vesce F, Gambari R, Mazzitelli S, Mancuso F, Luca G, Nastruzzi C, Piva R: Encapsulation of mesenchymal stem cells from Wharton’s jelly in alginate microbeads. Tissue Eng Part C Methods. 2010, 16 (1): 141-155. 10.1089/ten.tec.2008.0582.CrossRefPubMed Penolazzi L, Tavanti E, Vecchiatini R, Lambertini E, Vesce F, Gambari R, Mazzitelli S, Mancuso F, Luca G, Nastruzzi C, Piva R: Encapsulation of mesenchymal stem cells from Wharton’s jelly in alginate microbeads. Tissue Eng Part C Methods. 2010, 16 (1): 141-155. 10.1089/ten.tec.2008.0582.CrossRefPubMed
41.
go back to reference Chen Y, Gelfond J, McManus LM, Shireman PK: Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682. Physiol Genomics. 2011, 43 (10): 621-630. 10.1152/physiolgenomics.00136.2010.CrossRefPubMed Chen Y, Gelfond J, McManus LM, Shireman PK: Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682. Physiol Genomics. 2011, 43 (10): 621-630. 10.1152/physiolgenomics.00136.2010.CrossRefPubMed
42.
go back to reference Ciaudo C, Servant N, Cognat V, Sarazin A, Kieffer E, Viville S, Colot V, Barillot E, Heard E, Voinnet O: Highly dynamic and sex-specific expression of microRNAs during early ES cell differentiation. PLoS Genet. 2009, 5 (8): e1000620-10.1371/journal.pgen.1000620.CrossRefPubMedPubMedCentral Ciaudo C, Servant N, Cognat V, Sarazin A, Kieffer E, Viville S, Colot V, Barillot E, Heard E, Voinnet O: Highly dynamic and sex-specific expression of microRNAs during early ES cell differentiation. PLoS Genet. 2009, 5 (8): e1000620-10.1371/journal.pgen.1000620.CrossRefPubMedPubMedCentral
43.
go back to reference Cailleau R, Olivé M, Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 1978, 14 (11): 911-915. 10.1007/BF02616120.CrossRefPubMed Cailleau R, Olivé M, Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 1978, 14 (11): 911-915. 10.1007/BF02616120.CrossRefPubMed
44.
go back to reference Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL: KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett. 1997, 119 (2): 149-155. 10.1016/S0304-3835(97)00273-5.CrossRefPubMed Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL: KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett. 1997, 119 (2): 149-155. 10.1016/S0304-3835(97)00273-5.CrossRefPubMed
45.
go back to reference Baranwal S, Alahari SK: Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun. 2009, 384 (1): 6-11. 10.1016/j.bbrc.2009.04.051.CrossRefPubMedPubMedCentral Baranwal S, Alahari SK: Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun. 2009, 384 (1): 6-11. 10.1016/j.bbrc.2009.04.051.CrossRefPubMedPubMedCentral
46.
go back to reference Kajita M, McClinic KN, Wade PA: Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol. 2004, 24 (17): 7559-7566. 10.1128/MCB.24.17.7559-7566.2004.CrossRefPubMedPubMedCentral Kajita M, McClinic KN, Wade PA: Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol. 2004, 24 (17): 7559-7566. 10.1128/MCB.24.17.7559-7566.2004.CrossRefPubMedPubMedCentral
47.
go back to reference Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J: Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. 2011, 30 (12): 1436-1448. 10.1038/onc.2010.509.CrossRefPubMed Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J: Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. 2011, 30 (12): 1436-1448. 10.1038/onc.2010.509.CrossRefPubMed
48.
go back to reference Hajra KM, Chen DY, Fearon ER: The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002, 62 (6): 1613-1618.PubMed Hajra KM, Chen DY, Fearon ER: The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002, 62 (6): 1613-1618.PubMed
49.
go back to reference Sakai D, Suzuki T, Osumi N, Wakamatsu Y: Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development. 2006, 133 (7): 1323-1333. 10.1242/dev.02297.CrossRefPubMed Sakai D, Suzuki T, Osumi N, Wakamatsu Y: Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development. 2006, 133 (7): 1323-1333. 10.1242/dev.02297.CrossRefPubMed
50.
go back to reference Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ: MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem. 2008, 283 (45): 31079-31086. 10.1074/jbc.M806041200.CrossRefPubMedPubMedCentral Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ: MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem. 2008, 283 (45): 31079-31086. 10.1074/jbc.M806041200.CrossRefPubMedPubMedCentral
Metadata
Title
Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells
Authors
Elisabetta Lambertini
Andrea Lolli
Federica Vezzali
Letizia Penolazzi
Roberto Gambari
Roberta Piva
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-445

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine